<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37038445</PMID><DateRevised><Year>2023</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1178-6469</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>International journal of tryptophan research : IJTR</Title><ISOAbbreviation>Int J Tryptophan Res</ISOAbbreviation></Journal><ArticleTitle>Interferon-gamma Mediated Metabolic Pathways in Hospitalized Patients During Acute and Reconvalescent COVID-19.</ArticleTitle><Pagination><StartPage>11786469231154244</StartPage><MedlinePgn>11786469231154244</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">11786469231154244</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/11786469231154244</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Fatigue, sleep disturbance, and neurological symptoms during and after COVID-19 are common and might be associated with inflammation-induced changes in tryptophan (Trp) and phenylalanine (Phe) metabolism.</AbstractText><AbstractText Label="AIM" NlmCategory="UNASSIGNED">This pilot study investigated interferon gamma inducible biochemical pathways (namely Trp catabolism, neopterin, tyrosine [Tyr], and nitrite formation) during acute COVID-19 and reconvalescence.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="UNASSIGNED">Thirty one patients with moderate to severe COVID-19 admitted to the University Hospital of Innsbruck in early 2020 (March-May) were followed up. Neurotransmitter precursors Trp, Phe, Tyr as well as kynurenine (Kyn), neopterin, nitrite, and routine laboratory parameters were analyzed during acute infection and at a follow-up (FU) 60&#x2009;days thereafter. Clinical symptoms of patients (neurological symptoms, fatigue, sleep disturbance) were recorded and associations with concentrations of laboratory parameters investigated.</AbstractText><AbstractText Label="RESULTS AND CONCLUSION" NlmCategory="UNASSIGNED">Almost half of the patients suffered from neurological symptoms (48.4%), the majority of patients experienced sleep difficulties (56.7%) during acute COVID-19. Fatigue was present in nearly all patients. C-reactive protein (CRP), interleukin-6 (IL-6), neopterin, Kyn, Phe concentrations were significantly increased, and Trp levels depleted during acute COVID-19. Patients with sleep impairment and neurological symptoms during acute illness presented with increased CRP and IL-6 concentrations, Trp levels were lower in patients with sleep disturbance. In general, inflammatory markers declined during reconvalescence. A high percentage of patients suffered from persistent symptoms at FU (neurological symptoms: 17.2%, fatigue: 51.7%, sleeping disturbance: 34.5%) and had higher CRP concentrations. Nitrite and Phe levels were lower in patients with sleeping difficulties at FU and Kyn/Trp ratio, as indicator of IDO activity, was significantly lower in patients with neurological symptoms compared to patients without them at FU. In summary, inflammation induced alterations of amino acid metabolism might be related to acute and persisting symptoms of COVID-19.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gietl</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burkert</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seiwald</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;hm</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hofer</LastName><ForeName>Stefanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gostner</LastName><ForeName>Johanna M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piater</LastName><ForeName>Talia</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geisler</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiss</LastName><ForeName>Guenter</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loeffler-Ragg</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sonnweber</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tancevski</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pizzini</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahanic</LastName><ForeName>Sabina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuchs</LastName><ForeName>Dietmar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellmann-Weiler</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurz</LastName><ForeName>Katharina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Medical University Innsbruck, Biocentre, Medical Biochemistry, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Tryptophan Res</MedlineTA><NlmUniqueID>101513378</NlmUniqueID><ISSNLinking>1178-6469</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">IDO</Keyword><Keyword MajorTopicYN="N">Long Covid</Keyword><Keyword MajorTopicYN="N">interferon-gamma</Keyword><Keyword MajorTopicYN="N">neopterin</Keyword><Keyword MajorTopicYN="N">phenylalanine</Keyword><Keyword MajorTopicYN="N">tryptophan</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>1</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37038445</ArticleId><ArticleId IdType="pmc">PMC10076985</ArticleId><ArticleId IdType="doi">10.1177/11786469231154244</ArticleId><ArticleId IdType="pii">10.1177_11786469231154244</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pujadas E, Chaudhry F, McBride R, et al.. SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Respir Med. 2020;8:e70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836878</ArticleId><ArticleId IdType="pubmed">32771081</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajnzylber J, Regan J, Coxen K, et al.. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020;11:5493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7603483</ArticleId><ArticleId IdType="pubmed">33127906</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini N, Clementi N, Ferrarese R, et al.. Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death. Clin Chem Lab Med. 2021;59:e247-e250.</Citation><ArticleIdList><ArticleId IdType="pubmed">33577724</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell MW, Moldoveanu Z, Ogra PL, Mestecky J.Mucosal immunity in COVID-19: a neglected but critical aspect of SARS-CoV-2 infection. Front Immunol. 2020;11:611337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7733922</ArticleId><ArticleId IdType="pubmed">33329607</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal M, Bangash HI, Habiba M, et al.. Immune dysregulation and system pathology in COVID-19. Virulence. 2021;12:918-936.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7993139</ArticleId><ArticleId IdType="pubmed">33757410</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkert FR, Lanser L, Bellmann-Weiler R, Weiss G.Coronavirus disease 2019: clinics, treatment, and prevention. Front Microbiol. 2021;12:761887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8631905</ArticleId><ArticleId IdType="pubmed">34858373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Q, Wang B, Mao J.The pathogenesis and treatment of the &#x2018;Cytokine Storm&#x2019; in COVID-19. J Infect. 2020;80:607-613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194613</ArticleId><ArticleId IdType="pubmed">32283152</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Guo H, Zhou P, Shi ZL.Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141-154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellmann-Weiler R, Lanser L, Burkert F, et al.. Neopterin predicts disease severity in hospitalized patients with COVID-19. Open Forum Infect Dis. 2021;8:ofaa521.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665702</ArticleId><ArticleId IdType="pubmed">33442554</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-1062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodr&#xed;guez L.SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62-75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7265853</ArticleId><ArticleId IdType="pubmed">32513566</ArticleId></ArticleIdList></Reference><Reference><Citation>Herold T, Jurinovic V, Arnreich C, et al.. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020; 146:128-136.e4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233239</ArticleId><ArticleId IdType="pubmed">32425269</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson J, Gostner JM, Nilsson S, Andersson LM, Fuchs D, Gisslen M.Serum neopterin levels in relation to mild and severe COVID-19. BMC Infect Dis. 2020;20:942.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7726600</ArticleId><ArticleId IdType="pubmed">33302893</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozger HS, Dizbay M, Corbacioglu SK, et al.. The prognostic role of neopterin in COVID-19 patients. J Med Virol. 2021;93:1520-1525.</Citation><ArticleIdList><ArticleId IdType="pubmed">32860465</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewulf JP, Martin M, Marie S, et al.. Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19. Sci Rep. 2022;12:9959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9198612</ArticleId><ArticleId IdType="pubmed">35705608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ero&#x11f;lu &#x130;, Ero&#x11f;lu B&#xc7;, G&#xfc;ven GS. Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19). Nutrition. 2021;90:111308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8087860</ArticleId><ArticleId IdType="pubmed">34111831</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A.The neurobiology of long COVID. Neuron. 2022;110: 3484-3496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN.Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4:e2111417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Schr&#xf6;cksnadel K, Wirleitner B, Winkler C, Fuchs D.Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta. 2006;364:82-90.</Citation><ArticleIdList><ArticleId IdType="pubmed">16139256</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroecksnadel K, Zangerle R, Bellmann-Weiler R, Garimorth K, Weiss G, Fuchs D.Indoleamine-2, 3-dioxygenase and other interferon-gamma-mediated pathways in patients with human immunodeficiency virus infection. Curr Drug Metab. 2007;8:225-236.</Citation><ArticleIdList><ArticleId IdType="pubmed">17430111</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroecksnadel K, Sarcletti M, Winkler C, et al.. Quality of life and immune activation in patients with HIV-infection. Brain Behav Immun. 2008;22:881-889.</Citation><ArticleIdList><ArticleId IdType="pubmed">18261883</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanser L, Kink P, Egger EM, et al.. Inflammation-induced tryptophan breakdown is related with anemia, fatigue, and depression in cancer. Front Immunol. 2020;11:249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7047328</ArticleId><ArticleId IdType="pubmed">32153576</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang A, Fuchs D, Widner B, Glover C, Henderson DC, Allen-Mersh TG.Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer. Br J Cancer. 2002;86:1691-1696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2375406</ArticleId><ArticleId IdType="pubmed">12087451</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner ER, Bitterlich G, Fuchs D, et al.. Human macrophages degrade tryptophan upon induction by interferon-gamma. Life Sci. 1987;41:273-280.</Citation><ArticleIdList><ArticleId IdType="pubmed">3110526</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RR, Ozaki Y, Datta SP, Borden EC, Sondel PM, Malone DG.Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS. Adv Exp Med Biol. 1991;294:425-435.</Citation><ArticleIdList><ArticleId IdType="pubmed">1722946</ArticleId></ArticleIdList></Reference><Reference><Citation>Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL.Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med. 1999;189:1363-1372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2193062</ArticleId><ArticleId IdType="pubmed">10224276</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA.Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol. 2000;164:3596-3599.</Citation><ArticleIdList><ArticleId IdType="pubmed">10725715</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawler NG, Gray N, Kimhofer T, et al.. Systemic perturbations in amine and kynurenine metabolism associated with acute SARS-CoV-2 infection and inflammatory cytokine responses. J Proteome Res. 2021;20:2796-2811.</Citation><ArticleIdList><ArticleId IdType="pubmed">33724837</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ.Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci. 2012;13:465-477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3681811</ArticleId><ArticleId IdType="pubmed">22678511</ArticleId></ArticleIdList></Reference><Reference><Citation>Canli T, Lesch KP.Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci. 2007;10:1103-1109.</Citation><ArticleIdList><ArticleId IdType="pubmed">17726476</ArticleId></ArticleIdList></Reference><Reference><Citation>Tordjman S, Chokron S, Delorme R, et al.. Melatonin: pharmacology, functions and therapeutic benefits. Curr Neuropharmacol. 2017;15:434-443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5405617</ArticleId><ArticleId IdType="pubmed">28503116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferracioli-Oda E, Qawasmi A, Bloch MH.Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013;8:e63773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3656905</ArticleId><ArticleId IdType="pubmed">23691095</ArticleId></ArticleIdList></Reference><Reference><Citation>Coon SL, Roseboom PH, Baler R, et al.. Pineal serotonin N-acetyltransferase: expression cloning and molecular analysis. Science. 1995;270:1681-1683.</Citation><ArticleIdList><ArticleId IdType="pubmed">7502081</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts I, Wright Muelas M, Taylor JM, et al.. Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome. Metabolomics. 2021;18:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8686810</ArticleId><ArticleId IdType="pubmed">34928464</ArticleId></ArticleIdList></Reference><Reference><Citation>Widner B, Fuchs D, Leblhuber F, Sperner-Unterweger B.Does disturbed homocysteine and folate metabolism in depression result from enhanced oxidative stress? J Neurol Neurosurg Psychiatry. 2001;70:419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1737240</ArticleId><ArticleId IdType="pubmed">11248907</ArticleId></ArticleIdList></Reference><Reference><Citation>Murr C, Gerlach D, Widner B, Dierich MP, Fuchs D.Neopterin production and tryptophan degradation in humans infected by Streptococcus pyogenes. Med Microbiol Immunol. 2001;189:161-163.</Citation><ArticleIdList><ArticleId IdType="pubmed">11388614</ArticleId></ArticleIdList></Reference><Reference><Citation>Koskenkorva-Frank TS, Weiss G, Koppenol WH, Burckhardt S.The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med. 2013;65:1174-1194.</Citation><ArticleIdList><ArticleId IdType="pubmed">24036104</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Liu H, McKenzie G, et al.. Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nat Med. 2010;16:279-285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3556275</ArticleId><ArticleId IdType="pubmed">20190767</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazio F, Carrizzo A, Lionetto L, et al.. Vasorelaxing action of the kynurenine metabolite, xanthurenic acid: the missing link in endotoxin-induced hypotension? Front Pharmacol. 2017;8:214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5410560</ArticleId><ArticleId IdType="pubmed">28507519</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma JN, Al-Omran A, Parvathy SS.Role of nitric oxide in inflammatory diseases. Inflammopharmacology. 2007;15:252-259.</Citation><ArticleIdList><ArticleId IdType="pubmed">18236016</ArticleId></ArticleIdList></Reference><Reference><Citation>Tousoulis D, Kampoli AM, Tentolouris C, Papageorgiou N, Stefanadis C.The role of nitric oxide on endothelial function. Curr Vasc Pharmacol. 2012;10:4-18.</Citation><ArticleIdList><ArticleId IdType="pubmed">22112350</ArticleId></ArticleIdList></Reference><Reference><Citation>Masoodi M, Peschka M, Schmiedel S, et al.. Disturbed lipid and amino acid metabolisms in COVID-19 patients. J Mol Med (Berl). 2022;100:555-568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8783191</ArticleId><ArticleId IdType="pubmed">35064792</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari M, Protti A.Nitric oxide in COVID-19: too little of a good thing? EBioMedicine. 2022;77:103925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8906241</ArticleId><ArticleId IdType="pubmed">35278744</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H, Han X, Jiang N, et al.. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20:425-434.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159053</ArticleId><ArticleId IdType="pubmed">32105637</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L, Jin H, Wang M, et al.. Neurologic manifestations of hospitalized patients with Coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77:683-690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Kremer S, Merdji H, et al.. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382:2268-2270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, et al.. Cardiopulmonary recovery after COVID-19 - an observational prospective multi-center trial. Eur Respir J. 2020; 57:2003481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Widner B, Werner ER, Schennach H, Wachter H, Fuchs D.Simultaneous measurement of serum tryptophan and kynurenine by HPLC. Clin Chem. 1997;43: 2424-2426.</Citation><ArticleIdList><ArticleId IdType="pubmed">9439467</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurauter G, Scholl-B&#xfc;rgi S, Haara A, et al.. Simultaneous measurement of phenylalanine and tyrosine by high performance liquid chromatography (HPLC) with fluorescence detection. Clin Biochem. 2013;46:1848-1851.</Citation><ArticleIdList><ArticleId IdType="pubmed">24183885</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisler S, Mayersbach P, Becker K, Schennach H, Fuchs D, Gostner JM.Serum tryptophan, kynurenine, phenylalanine, tyrosine and neopterin concentrations in 100 healthy blood donors. Pteridines. 2015;26:31-36.</Citation></Reference><Reference><Citation>Neurauter G, Schr&#xf6;cksnadel K, Scholl-B&#xfc;rgi S, et al.. Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr Drug Metab. 2008;9: 622-627.</Citation><ArticleIdList><ArticleId IdType="pubmed">18781914</ArticleId></ArticleIdList></Reference><Reference><Citation>Oken MM, Creech RH, Tormey DC, et al.. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-656.</Citation><ArticleIdList><ArticleId IdType="pubmed">7165009</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisler S, Lytton SD, Toan NL, et al.. Neopterin levels and Kyn/Trp ratios were significantly increased in dengue virus patients and subsequently decreased after recovery. Int J Infect Dis. 2020;91:162-168.</Citation><ArticleIdList><ArticleId IdType="pubmed">31821895</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzini A, Kurz K, Santifaller J, et al.. Assessment of neopterin and indoleamine 2,3-dioxygenase activity in patients with seasonal influenza: a pilot study. Influenza Other Respir Viruses. 2019;13:603-609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6800299</ArticleId><ArticleId IdType="pubmed">31489989</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellmann-Weiler R, Schroecksnadel K, Holzer C, Larcher C, Fuchs D, Weiss G.IFN-gamma mediated pathways in patients with fatigue and chronic active Epstein Barr virus-infection. J Affect Disord. 2008;108:171-176.</Citation><ArticleIdList><ArticleId IdType="pubmed">17945348</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;rc&#xfc; S, Girgin G, Yorulmaz G, K&#x131;l&#x131;&#xe7;arslan B, Efe B, Baydar T.Neopterin and biopterin levels and tryptophan degradation in patients with diabetes. Sci Rep. 2020;10:17025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7552423</ArticleId><ArticleId IdType="pubmed">33046801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Veldhuis A, Malhotra T.Neuropsychiatric and cognitive sequelae of COVID-19. Front Psychol. 2021;12:577529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7960660</ArticleId><ArticleId IdType="pubmed">33737894</ArticleId></ArticleIdList></Reference><Reference><Citation>Borah P, Deb PK, Chandrasekaran B, et al.. Neurological consequences of SARS-CoV-2 infection and concurrence of treatment-induced neuropsychiatric adverse events in COVID-19 patients: navigating the uncharted. Front Mol Biosci. 2021;8:627723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930836</ArticleId><ArticleId IdType="pubmed">33681293</ArticleId></ArticleIdList></Reference><Reference><Citation>Jasti M, Nalleballe K, Dandu V, Onteddu S.A review of pathophysiology and neuropsychiatric manifestations of COVID-19. J Neurol. 2021;268:2007-2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7268182</ArticleId><ArticleId IdType="pubmed">32494854</ArticleId></ArticleIdList></Reference><Reference><Citation>Irwin MR, Olmstead R, Carroll JE.Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry. 2016;80:40-52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4666828</ArticleId><ArticleId IdType="pubmed">26140821</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisor JP, Holmedahl NH, Saxvig IW, et al.. Effect of dietary nitrate supplementation on sleep in chronic obstructive pulmonary disease patients. Nat Sci Sleep. 2021;13:435-446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8007562</ArticleId><ArticleId IdType="pubmed">33790676</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>